Oxurion (TBGNF) News Today → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free TBGNF Stock Alerts $0.17 0.00 (0.00%) (As of 09/19/2023) Add Compare Share Share HeadlinesStock AnalysisHeadlinesStock AnalysisHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineOxurion NV: Oxurion Receives EUR 450,000 in the framework of the Atlas Funding Program: Eleventh tranche fully issued and paid-upfinanznachrichten.de - April 10 at 3:57 PMOxurion Receives EUR 450,000 in the framework of the Atlas Funding Program : Eleventh tranche fully issued and paid-upmarkets.businessinsider.com - April 10 at 3:57 PMOxurion NV: Postponement Annual Shareholders Meeting - Amendment financial calendarfinanznachrichten.de - April 5 at 8:41 AMOxurion NV: Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas - Amended versionfinanznachrichten.de - March 27 at 5:25 PMOxurion Receives EUR 300,000 in the framework of the Atlas Funding Program Tenth tranche fully issued and paid-upfinance.yahoo.com - March 5 at 2:18 PMOxurion NV: Oxurion Announces New Strategic Orientation to De-risk and Diversifyfinanznachrichten.de - January 22 at 7:09 PMOxurion Avoids Bankruptcy, Announces Board and Management Changes and Enters into Binding Letter of Intent with its Main Creditor Atlasfinance.yahoo.com - December 28 at 6:15 PMOxurion Discloses Topline Data from KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edemauk.finance.yahoo.com - November 20 at 9:42 AMOxurion NV OXURmorningstar.com - November 14 at 8:32 AMOxurion Announces Key Amendments to Atlas and Kreos/Pontifax Agreements Enabling KALAHARI Trial to Progress to Topline Results in 2023uk.finance.yahoo.com - October 1 at 10:23 PMOxurion Publishes First Half 2023 Resultsuk.finance.yahoo.com - September 29 at 10:57 PMOxurion Receives First EUR 1 Million under Amended Atlas Funding Programfinance.yahoo.com - September 19 at 8:55 AMOxurion unlocks $1m from Atlas for diabetic macular oedema therapymsn.com - August 11 at 7:42 PMOxurion NV: Oxurion Receives Funding of EUR One Million under Atlas Special Opportunities LLC (Atlas) Funding Programfinanznachrichten.de - August 11 at 3:10 AMOxurion NV (TG4.BE)uk.finance.yahoo.com - August 8 at 5:30 PMOxurion NV: Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLfinanznachrichten.de - July 27 at 3:58 AMOxurion Receives Transparency Notifications from Atlas Special Opportunities LLfinance.yahoo.com - July 27 at 3:58 AMOxurion NV: Oxurion Receives Upfront Payment of $400,000 Following Oncurious Asset License by VIBfinanznachrichten.de - July 25 at 9:04 PMOxurion Receives Upfront Payment of $400,000 Following Oncurious Asset License by VIBfinance.yahoo.com - July 25 at 8:29 AMOxurion Issues EUR 1.0 million in Bonds for Tranche 3 of the Funding Program with Atlas Special Opportunities LLCfinance.yahoo.com - June 15 at 5:42 PMOxurion to Participate in Upcoming Conferencesfinance.yahoo.com - June 1 at 2:50 AMOxurion NV: Oxurion Reaches Enrollment Target in KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edemafinanznachrichten.de - May 25 at 7:08 PMOxurion Issues EUR 2.0 million in Bonds for Tranche 2 of the Funding Program with Atlas Special Opportunities LLCfinance.yahoo.com - May 22 at 2:50 PMOxurion NV: Oxurion Issues EUR 2.0 million in Bonds for Tranche 1 (B) of the Funding Program with Atlas Special Opportunities LLCfinanznachrichten.de - April 27 at 1:25 PMOxurion Issues EUR 2.0 million in Bonds for Tranche 1 (B) of the Funding Program with Atlas Special Opportunities LLCfinance.yahoo.com - April 27 at 1:25 PMOxurion Receives Transparency Notifications from Atlas Special Opportunities LLCfinance.yahoo.com - April 24 at 3:16 PMOxurion NV: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLCfinanznachrichten.de - April 14 at 2:48 PMOxurion Receives Transparency Notification from Atlas Special Opportunities LLCtechnews.tmcnet.com - April 14 at 2:48 PMInformation on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLASbenzinga.com - April 9 at 2:21 PMOxurion NV: Oxurion Publishes 2022 Annual Reportfinanznachrichten.de - April 2 at 12:18 AMOxurion NV: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLASfinanznachrichten.de - March 31 at 11:15 PMOxurion NV: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLAfinanznachrichten.de - March 25 at 9:38 AMOxurion NV: Oxurion Issues EUR 2.8 million in Bonds for Tranche 1 (A) of Funding Program with Atlas Special Opportunities LLfinanznachrichten.de - March 22 at 12:48 PMOxurion Issues EUR 2.8 million in Bonds for Tranche 1 (A) of Funding Program with Atlas Special Opportunities LLfinance.yahoo.com - March 20 at 11:16 PMOxurion NV: Oxurion Receives Transparency Notification from Negma Groupfinanznachrichten.de - March 4 at 7:02 PMOxurion Receives Transparency Notification from Negma Groupfinance.yahoo.com - March 2 at 5:25 PMOxurion Announces Subscription Agreement with Atlas Providing the Company with Up To €20 Million in Fundingfinance.yahoo.com - March 2 at 7:24 AMFunding Program between Oxurion and Negma Endsfinance.yahoo.com - March 2 at 7:24 AMOxurion NV: Oxurion Receives Transparency Notificationsfinanznachrichten.de - February 10 at 2:23 PMOxurion NV: Oxurion Receives Transparency Notifications from Negma Groupfinanznachrichten.de - February 3 at 2:51 PMOxurion Receives Transparency Notifications from Negma Groupfinance.yahoo.com - February 3 at 2:51 PMOxurion Provides Further Details Concerning the Second Amendment to Negma Funding Programyahoo.com - January 27 at 7:31 AMOxurion NV (OXUR.BR)finance.yahoo.com - January 26 at 3:53 PMOxurion Announces Second Amendment to Negma Funding Programuk.news.yahoo.com - January 25 at 7:54 AMOxurion Further Improves THR-149 Patent Positionfinance.yahoo.com - November 23 at 12:58 PMOxurion Announces Interim Analysis for KALAHARI Trialfinance.yahoo.com - November 18 at 5:53 PMOxurion Receives Transparency Notifications Based on New Denominatorfinance.yahoo.com - November 17 at 7:13 AMOxurion Receives Transparency Notification from Fidelity Management & Research Company LLCbenzinga.com - November 4 at 5:48 PMOxurion To Participate in Upcoming Investor Conferencesfinance.yahoo.com - October 18 at 7:03 PMOxurion NV: Oxurion To Participate in Upcoming Scientific and Investor Conferencesfinanznachrichten.de - September 12 at 5:00 PM Get Oxurion News Delivered to You Automatically Sign up to receive the latest news and ratings for TBGNF and its competitors with MarketBeat's FREE daily newsletter. Email Address World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea. Click here to find out what to do. TBGNF Media Mentions By Week TBGNF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TBGNF News Sentiment▼0.000.41▲Average Medical News Sentiment TBGNF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TBGNF Articles This Week▼00▲TBGNF Articles Average Week Get Oxurion News Delivered to You Automatically Sign up to receive the latest news and ratings for TBGNF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Algernon Pharmaceuticals News ALK-Abelló A/S News Alpha Tau Medical News Arno Therapeutics News Artelo Biosciences News Ascletis Pharma News Awakn Life Sciences News AXIM Biotechnologies News BerGenBio ASA News BriaCell Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:TBGNF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxurion NV Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
